EN
抗体药类似物
Research Grade Reozalimab
All
TD-HV974216_1.jpg
TD-HV974216_2.jpg
  • CatalogTD-HV974216
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,IBI318,IBI-318,IBI318,CAS:2445259-99-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Reozalimab


Catalog No. TD-HV974216
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype Ig(G1-kappa_G1-lambda2)
Expression system Mammalian Cells
Clonality Monoclonal
Target B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9NZQ7 & Q15116
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,IBI318,IBI-318,IBI318,CAS:2445259-99-2
Background Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV974216_1.jpg
Bioactivity
 
Detects PDL1 in indirect ELISA.
TD-HV974216_2.jpg
Bioactivity
 
Detects recombinant human PD1 (Cat No.: TD-HS870021) in indirect ELISA.